LP-922761 is a potent and selective AAK1 inhibitor with an in vitro IC50 of 4.8 ± 0.8 nM and a cellular IC50 of 7.6 ± 0.7 nM. References: Kostich W, Hamman BD, Li Y-W, et al. Inhibition of AAK1 Kinase as a Novel Therapeutic Approach to Treat Neuropathic Pain. The Journal of Pharmacology and Experimental Therapeutics. 2016;358(3):371-386. doi:10.1124/jpet.116.235333.

纯度：≥98%

CAS：1454808-95-7